Literature DB >> 2531618

Bronchodilator effect of atrial natriuretic peptide in asthma.

G Hulks1, A Jardine, J M Connell, N C Thomson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2531618      PMCID： PMC1837941          DOI： 10.1136/bmj.299.6707.1081

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Relaxant activity of atriopeptins in isolated guinea pig airway and vascular smooth muscle.

Authors:  M O'Donnell; R Garippa; A F Welton
Journal:  Peptides       Date:  1985 Jul-Aug       Impact factor: 3.750

2.  Relaxant profile of synthetic atrial natriuretic factor on guinea-pig pulmonary tissues.

Authors:  R Hamel; A W Ford-Hutchinson
Journal:  Eur J Pharmacol       Date:  1986-02-11       Impact factor: 4.432

3.  Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods.

Authors:  A M Richards; G Tonolo; G D McIntyre; B J Leckie; J I Robertson
Journal:  J Hypertens       Date:  1987-04       Impact factor: 4.844
  3 in total
  17 in total

1.  Inhaled atrial natriuretic peptide and asthmatic airways.

Authors:  G Hulks; N C Thomson
Journal:  BMJ       Date:  1992-05-02

2.  Effect of inhaled thiorphan, a neutral endopeptidase inhibitor, on the bronchodilator response to inhaled atrial natriuretic peptide (ANP).

Authors:  R M Angus; E A Millar; G W Chalmers; N C Thomson
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

Review 3.  Atrial natriuretic factor: the heart as an endocrine organ.

Authors:  T J Stephenson; F Broughton Pipkin
Journal:  Arch Dis Child       Date:  1990-12       Impact factor: 3.791

4.  Humoral control of airway tone.

Authors:  N C Thomson; K D Dagg; S G Ramsay
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

5.  Localization of the bronchodilator effect induced by type A natriuretic peptide in asthmatic subjects.

Authors:  T Flüge; H Fabel; T O Wagner; W G Forssmann
Journal:  Clin Investig       Date:  1994-10

6.  In vitro and in vivo pharmacological profile of PL-3994, a novel cyclic peptide (Hept-cyclo(Cys-His-Phe-d-Ala-Gly-Arg-d-Nle-Asp-Arg-Ile-Ser-Cys)-Tyr-[Arg mimetic]-NH(2)) natriuretic peptide receptor-A agonist that is resistant to neutral endopeptidase and acts as a bronchodilator.

Authors:  Jeffrey D Edelson; Marie Makhlina; Kevin R Silvester; Shailesh S Vengurlekar; Xiaomei Chen; Jie Zhang; Cynthia J Koziol-White; Philip R Cooper; Trevor J Hallam; Douglas W P Hay; Reynold A Panettieri
Journal:  Pulm Pharmacol Ther       Date:  2012-11-12       Impact factor: 3.410

7.  Plasma concentration of human atrial natriuretic hormone in patients with connective tissue diseases.

Authors:  M Yasuda; D Yasuda; K Tomooka; M Nobunaga
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

Review 8.  The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature.

Authors:  R I Cargill; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

9.  Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.

Authors:  S C Ijioma; R A Challiss; J P Boyle
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

10.  Bronchodilator and pre-protective effects of urodilatin in bovine bronchi in vitro: comparison with atrial natriuretic peptide.

Authors:  J E Nally; C C Docherty; R A Clayton; N C Thomson
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.